| 臺大學術典藏 |
2022-05-05T09:10:38Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
WEI-CHU CHIE; Hong R.-L.; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2022-05-05T08:48:57Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L.; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; CHIA-CHUN WANG; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2022-05-05T08:48:57Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L.; Sheen T.S.; Ko J.Y.; Hsu M.M.; CHIA-CHUN WANG; Ting L.L. |
| 臺大學術典藏 |
2022-04-21T06:51:36Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.; Chen, Tony Hsiu Hsi; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; Hong R.-L. |
| 臺大學術典藏 |
2022-03-04T06:53:46Z |
Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma
|
Ko J.-Y.; Wang C.-P.; Ting L.-L.; Yang T.-L.; CHING-TING TAN |
| 臺大學術典藏 |
2021-11-18T04:58:21Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-18T04:58:20Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-18T04:58:14Z |
Postirradiated neuroendocrine carcinoma of the sinonasal tract
|
Wang C.-P; Hsieh C.-Y; Chang Y.-L; Lou P.-J; Yang T.-L; Ting L.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-18T04:58:12Z |
Malignant fibrous histiocytoma of the sinonasal tract
|
Wang C.-P; Chang Y.-L; Ting L.-L; Yang T.-L; JENG-YUH KO; Lou P.-J. |
| 臺大學術典藏 |
2021-11-18T04:58:12Z |
Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma
|
Lo W.-C; Ting L.-L; JENG-YUH KO; Lou P.-J; Yang T.-L; Chang Y.-L; Wang C.-P. |
| 臺大學術典藏 |
2021-11-18T04:58:10Z |
Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma
|
JENG-YUH KO; Wang C.-P; Ting L.-L; Yang T.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-18T04:58:09Z |
Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck
|
Chen T.-C; Wang C.-T; JENG-YUH KO; Lou P.-J; Yang T.-L; Ting L.-L; Wang C.-W; Hu Y.-L; Wang C.-P. |
| 臺大學術典藏 |
2021-11-18T04:58:09Z |
Recurrent Nasopharyngeal Carcinoma Presenting as a Positron Emission Tomography False-negative Scan
|
Shih C; JENG-YUH KO; Wang C.-P; Ting L.-L; Hsiao J.-K. |
| 臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-15T07:48:45Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:42Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-15T07:48:41Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-15T07:48:38Z |
Postirradiated neuroendocrine carcinoma of the sinonasal tract
|
Wang C.-P; Hsieh C.-Y; Chang Y.-L; Lou P.-J; Yang T.-L; Ting L.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-15T07:48:35Z |
Malignant fibrous histiocytoma of the sinonasal tract
|
Wang C.-P; Chang Y.-L; Ting L.-L; Yang T.-L; JENG-YUH KO; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:35Z |
Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma
|
Lo W.-C; Ting L.-L; JENG-YUH KO; Lou P.-J; Yang T.-L; Chang Y.-L; Wang C.-P. |
| 臺大學術典藏 |
2021-11-15T07:48:32Z |
Recurrent Nasopharyngeal Carcinoma Presenting as a Positron Emission Tomography False-negative Scan
|
Shih C; JENG-YUH KO; Wang C.-P; Ting L.-L; Hsiao J.-K. |
| 臺大學術典藏 |
2021-11-15T07:48:32Z |
Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma
|
JENG-YUH KO; Wang C.-P; Ting L.-L; Yang T.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-15T07:48:31Z |
Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck
|
Chen T.-C; Wang C.-T; JENG-YUH KO; Lou P.-J; Yang T.-L; Ting L.-L; Wang C.-W; Hu Y.-L; Wang C.-P. |
| 臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-10-18T06:51:41Z |
A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients
|
Cheng S.-J.; Lee J.-J.; Ting L.-L.; Tseng I.-Y.; Chang H.-H.; HSIN-MING CHEN; Kuo Y.-S.; Hahn L.-J.; Kok S.-H. |
| 臺大學術典藏 |
2021-07-07T03:41:30Z |
A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients
|
SHIH-JUNG CHENG; Lee J.-J.; Ting L.-L.; Tseng I.-Y.; Chang H.-H.; Chen H.-M.; Kuo Y.-S.; Hahn L.-J.; Kok S.-H. |
| 臺大學術典藏 |
2021-07-07T01:47:04Z |
A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients
|
Cheng S.-J.; JANG-JAER LEE; Ting L.-L.; Tseng I.-Y.; Chang H.-H.; Chen H.-M.; Kuo Y.-S.; Hahn L.-J.; Kok S.-H. |
| 臺大學術典藏 |
2021-07-06T04:08:59Z |
A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients
|
Cheng S.-J.; Lee J.-J.; Ting L.-L.; Tseng I.-Y.; Chang H.-H.; Chen H.-M.; Kuo Y.-S.; Hahn L.-J.; SANG-HENG KOK |
| 臺大學術典藏 |
2021-04-28T06:58:26Z |
Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck
|
Chen T.-C.; Wang C.-T.; Ko J.-Y.; Lou P.-J.; Yang T.-L.; Ting L.-L.; CHUN-WEI WANG; Hu Y.-L.; Wang C.-P. |
| 臺大學術典藏 |
2021-04-28T06:58:18Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L.; Hsiao C.F.; Ting L.L.; Ko J.Y.; CHUN-WEI WANG; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
| 臺大學術典藏 |
2021-03-19T06:57:47Z |
Effects of functional electrical stimulation on dysphagia caused by radiation therapy in patients with nasopharyngeal carcinoma
|
Lin P.-H.;Hsiao T.-Y.;Yeun-Chung Chang;Ting L.-L.;Chen W.-S.;Chen S.-C.;Wang T.-G.; Lin P.-H.; Hsiao T.-Y.; YEUN-CHUNG CHANG; Ting L.-L.; Chen W.-S.; Chen S.-C.; Wang T.-G. |
| 臺大學術典藏 |
2021-03-19T06:57:45Z |
A 2-year follow-up of swallowing function after radiation therapy in patients with nasopharyngeal carcinoma
|
Yeun-Chung Chang;Chen S.-Y.;Ting L.-L.;Peng S.S.-F.;Wang T.-C.;Wang T.-G.; YEUN-CHUNG CHANG; Chen S.-Y.; Ting L.-L.; Peng S.S.-F.; Wang T.-C.; Wang T.-G. |
| 臺大學術典藏 |
2021-03-18T08:54:43Z |
Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma
|
Yen R.-F.; Ting L.-L.; Cheng M.-F.; YEN-WEN WU; Tzen K.-Y.; Hong R.-L. |
| 臺大學術典藏 |
2021-03-18T05:59:18Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.; Chen T.H.-H.; Ting L.-L.; KAI-YUAN TZEN; Pan M.-H.; Hong R.-L. |
| 臺大學術典藏 |
2021-03-18T05:59:13Z |
Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma
|
Yen R.-F.; Ting L.-L.; Cheng M.-F.; Wu Y.-W.; KAI-YUAN TZEN; Hong R.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:19Z |
Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period
|
Chen H.H.W.;Fong L.;Su I.-J.;Ting L.-L.;Ruey-Long Hong;Leung H.W.C.;Lui L.T.; Chen H.H.W.; Fong L.; Su I.-J.; Ting L.-L.; RUEY-LONG HONG; Leung H.W.C.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Ruey-Long Hong;Sheen T.S.;Ko J.Y.;Hsu M.M.;Wang C.C.;Ting L.L.; RUEY-LONG HONG; Sheen T.S.; Ko J.Y.; Hsu M.M.; Wang C.C.; Ting L.L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M.;Chiou C.-R.;Ko J.-Y.;Sheen T.-S.;Ruey-Long Hong;Ting L.-L.; Hsu M.-M.; Chiou C.-R.; Ko J.-Y.; Sheen T.-S.; RUEY-LONG HONG; Ting L.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M.;Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Sheen T.-S.;Lou P.-J.; Hsu M.-M.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Hsu M.-M.;Sheen T.-S.;Lou P.-J.;Wang C.-C.;Chung N.-N.;Lui L.T.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
Chie W.-C.;Ruey-Long Hong;Lai C.-C.;Ting L.-L.;Hsu M.-M.; Chie W.-C.; RUEY-LONG HONG; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Ruey-Long Hong;Lin C.-Y.;Ting L.-L.;Ko J.-Y.;Hsu M.-M.; RUEY-LONG HONG; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.;Chen T.H.-H.;Ting L.-L.;Tzen K.-Y.;Pan M.-H.;Ruey-Long Hong; Yen R.-F.; Chen T.H.-H.; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma
|
Yen R.-F.; Ting L.-L.; Cheng M.-F.; Wu Y.-W.; Tzen K.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Ruey-Long Hong;Hsiao C.F.;Ting L.L.;Ko J.Y.;Wang C.W.;Chang J.T.C.;Lou P.J.;Wang H.M.;Tsai M.H.;Lai S.C.;Liu T.W.; RUEY-LONG HONG; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
